Alzheimer's Society
Jump to: content Jump to: navigation   Accessibility Contact Us Mobile Shop

Go to Graphical version

 

Dementia research funding must triple, say experts

Published 30 June 2009

The UK’s leading dementia charities united with eminent scientists to urge the government to commit to a national dementia research strategy and triple annual investment to £96 million in five years.

The Alzheimer's Research Trust and Alzheimer's Society revealed that the UK government lags behind France, Germany and the US in dementia research funding and has no plans for the future. They called on the government to exploit the UK's huge scientific talent and lead the world in the race for a cure.

In a joint statement launched ahead of the government's forthcoming Dementia Research Summit due to take place this summer, the charities set out priorities and opportunities for dementia research. Significant opportunities in dementia research include improving diagnosis, genetic research, improving care, and utilising the NHS in clinical trials.  

Neil Hunt, Chief Executive of Alzheimer's Society, says,

'Dementia is the health challenge of our generation, it is absolutely vital that dementia research funding is tripled. One million people will develop dementia in the next ten years, yet the government invests just 2% of its medical research budget on dementia.

The Dementia Research Summit must be more than just a talking shop. It is a crucial opportunity for the government, charities and stakeholders to commit to a shared vision for dementia research. We need an ambitious plan that drives change and defeats this devastating condition.'

Rebecca Wood, Chief Executive of the Alzheimer's Research Trust, says,

'700,000 people in the UK live with dementia, costing our economy £17 billion annually. Given the stakes, the government cannot afford to get its dementia research policy wrong.

'Spending £96 million per year would put the UK proportionately on a par with other world-leaders like the United States, and bring funding per person with dementia up to a similar level to government investment in cancer research.'

-Ends-

Notes to editors

The Alzheimer's Research Trust and Alzheimer's Society's joint statement calls for

  • A comprehensive plan that addresses cause, cure, care and public health research.
  • Joint engagement by the government, the research community, charities, people with dementia, carers and pharmaceutical companies to make this happen.
  • Actions to make NHS patients routinely aware that they may participate in research studies.
  • Steps to support and grow the dementia research community to meet the growing research demands over the next five years.

About the Alzheimer's Research Trust

The Alzheimer's Research Trust is the UK's leading dementia research charity and provides free information on Alzheimer's disease and related dementias: phone 01223 843899 or visit alzheimers-research.org.uk. The charity relies solely on public donations to fund its research.

About Alzheimer's Society

Alzheimer's Society is the UK's leading care and research charity for people with all forms dementia and their carers. It provides information and education, support for carers, and quality day and home care. It funds medical and scientific research and campaigns for improved health and social services and greater public understanding of dementia.

The Alzheimer's Society provides a national help line on 0845 3000 336 and website alzheimers.org.uk. Please include this information in any publication that uses these.